Researchers identify novel therapeutic target to improve recovery after nerve injury
Peripheral nerve injury reduces the ability of macrophages to clear dead or dying cells – a process known as efferocytosis – leading to chronic pain
Restoring efferocytosis ability reduced neuropathic pain in lab models
Efferocytosis is a potential therapeutic target for chronic neuropathic pain
Researchers at The University of Texas MD Anderson Cancer Center have discovered that targeting a specific immune process could help improve...
High levels of protein drive tumor immune suppression in head and neck cancer
BATF2 is a new type of tumor suppressor that can be epigenetically silenced by high levels of glutamine in the tumor microenvironment
Glutamine...
Circadian rhythms may affect risk of bacterial infection
Researchers identified an inflammation biomarker in laboratory model that predicts which individuals are at an increased risk of bacterial infection...